DNA mismatch repair genes and colorectal cancer

Gut

Volumn 47, Issue 1, 2000, Pages 148-153

  Wheeler, J M D ^a   Bodmer, W F ^a   McC Mortensen, N J ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ENZYME; CELL DNA; CYCLINE; MICROSATELLITE DNA; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; REPLICATION FACTOR C; REPLICATION PROTEIN A;

ADENOMATOUS POLYP; APOPTOSIS; BASE MISPAIRING; CANCER GROWTH; CANCER RESEARCH; CHROMOSOME 2P; CHROMOSOME MAP; COLON CARCINOGENESIS; COLORECTAL CANCER; DNA METHYLATION; DNA REPAIR; DNA SEQUENCE; GENE EXPRESSION; GENE INACTIVATION; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; MEDICAL LITERATURE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

BASE PAIR MISMATCH; COLORECTAL NEOPLASMS; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA REPAIR; DNA, NEOPLASM; HUMANS; MICROSATELLITE REPEATS;

EID: 0033946039     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.47.1.148     Document Type: Review

References (109)

1. Warthin AS. Heredity with reference to carcinoma. Arch Intern Med 1913;12:546-55.
2. VTarthin AS. Heredity of carcinoma in man. Ann Intern Med 1931 ;4:681-96.
3. Lynch HT, Shaw MV, Magnuson CV, Larsen AL, Krush AJ. Hereditary factors in cancer. Study of two large midwestern kindreds. Arch Intern Med 1966;117:206-12.
4. Lynch HT, Krush AJ. Cancer family "G" revisited: 1895-1970. Cancer 1971;27:1505-11.
5. Mecklin JP, Jarvinen HJ, Peltokallio P. Cancer family syndrome. Genetic analysis of 22 Finnish kindreds. Gastrocntcrology 1986;90:328-33.
6. ö Ponz de Leon M, Sassatelli R, Sacchetti C, Zanghieri G, Scalmati A, Roncucci L. Familial aggregation of tumors in the three-year experience of a population-based colorectal cancer registry. Cancer Res 1989;49:4344-8.
7. Boland CR, Troncale FJ. Familial colonie cancer without antecedent polyposis./4ii Imcrn Med 1984;100:700-1.
8. Peltomaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-12.
9. Lindblom A, Tannergard P, Verelius B, Nordenskjold M. Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 1993;5:279-82.
10. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993;260:812-16.
11. Fishel R, Lescoe MK, Rao MR, et al. The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 1993;75:1027-38.
12. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell 1993;75:1215-25.
13. Bronner CE, Baker SM, Morrison PT, et at. Mutation in the DNA mismatch 'repair gene homologue hMLH 1 is associated with hereditary non-polyposis colon cancer. Nature 1994;36S:258-61.
14. Papadopoulos N, Nicolaides NC, Vei YF, et al. Alutation of a mut homolog in hereditary colon cancer. Science 1994;263:1625-9.
15. Eshleman JR, Markowitz SD. Mismatch repair defects in human carcinogenesis. Hum Mol Genet 1996;5:1489-94.
16. Nicolaides NC, Papadopoulos N, Liu B, ct al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 1994;371:75-80.
17. Risinger JI, Umar A, Boyd J, Berchuck A, Kunkel TA, Barrett JC. Mutation of MSH3 in endometrial cancer and evidence for its functional role in heteroduplex repair. Nat Genet 1996;14:102-5.
18. Palombo F, Gallinari P, laccarino I, et al. GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 1995;26S: 1912-14.
19. Akiyama Y, Sato H, Yamada T, et al. Germ-line mutation of the hMSH6/GTBP gene in an atypical hereditary nonpolyposis colorectal cancer kindred. Cancer Res 1997;S7:3920-3.
20. Miyaki M, Konishi M, Tanaka K, et al. Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer (letter). Nat Genet 1997; 17:271-2.
21. Papadopoulos N, Nicolaides NC, Liu B, el al. Mutations of GTBP in genetically unstable cells. Science 1995;26S:1915-17.
22. Aaltonen LA, Peltomaki P, Mecklin JP, et al. Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 1994;54:1645-8.
23. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-19.
24. Arzimanoglou II, Gilbert F, Barber HR. Microsatellite instability in human solid tumors. Cancer 1998;S2:1808-20.
25. Lothe RA, Peltomaki P, Meling GI, et al. Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. Cancer Res 1993;53:5849-52.
26. Jass JR, Cottier DS, Jeevaratnam P, et ai. Diagnostic use of microsatellite instability in hereditary non-polyposis colorectal cancer. Lancet 1995;346: 1200-1.
27. Percesepe A, Kristo P, Aaltonen LA, Ponz de Leon M, de la Chapelle A, Peltomaki P. Mismatch repair genes and mononucleotide tracts as mutation targets in colorectal tumors with different degrees of microsatellite instability. Oncogene 1998;17:157-63.
28. Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, Hamelin R. BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 1997;57:300-3.
29. Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 1998;5S:5248-57.
30. Rodriguez-Bigas MA, Boland CR, Hamilton SR, et al. A National Cancer Institute workshop on hereditary nonpolyposis colorectal cancer syndrome: meeting highlights and Bethesda guidelines. J Nail Cancer Iml 1997;S9: 1758-62.
31. Lynch HT, Smyrk T. Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996;78:1149-67.
32. Thorson AG, Knezetic JA, Lynch HT. A century of progress in hereditary nonpolyposis colorectal cancer (Lynch syndrome). Dis Colon Rectum 1999; 42:1-9.
33. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. NEnglJMed 1998;33S:1481-7.
34. Lynch HT, Smyrk T, Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cywgenct 1997;93:84-99.
35. Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer 1993;71:677-85.
36. Lynch HT, Lynch JF. Genetics of colonie cancer. Digestion 1998;59:481-92.
37. Hamilton SR, Liu B, Parsons RE, et al. The molecular basis of Turcot's syndrome. NEnglJMcd 1995;332:839-47.
38. Swale VJ, Quinn AG, Wheeler JMD, et al. Microsatellite instability in benign skin lesions in hereditary non-polyposis colorectal cancer syndrome. J Im-est Dermatol 1999;113:901-5.
39. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Mcd 1996;2: 169-74.
40. Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997;6:105-10.
41. Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroemerology 1996;110:1020-7.
42. Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology 1997;113:1146-58.
43. Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICGHNPCC). OH Colon Rectum 1991;34:424-5.
44. Vasen HFA, Ytatson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch Syndrome) proposed by the International Collaborative Group on HNPCC. Gasirocnterology 1999;! 16:1453-6.
45. lonov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonie carcinogenesis. Nature 1993;363:558-61.
46. Knudson AG Mutation and cancer: statistical study of retinoblastoma. Proc Nad Acad Sei USA 1971;6S:820-3.
47. Liu B, Nicolaides NC, Markowitz S, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet 1995; 9:48-55.
48. Borresen AL, Lothe RA, Meling GI, el al. Somatic mutations in the hMSH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet 1995;4:2065-72.
49. Katabuchi H, van Rees B, Lambers AR, et al. Aïutations in DMA mismatch repair genes are not responsible for microsatellite instability in most sporadic endometrial carcinomas. Cancer Res 1995;55:5556-60.
50. Fujita M, Enomoto T, Yoshino K, et al. Microsatellite instability and alterations in the hMSH2 gene in human ovarian cancer. Im J Cancer 1995;64: 361-6.
51. Thibodeau SN, French AJ, Cunningham JM, et al. Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH 1. Cancer Res 1998;58:1713-18.
52. Kolodner R. Biochemistry and genetics of eukaryotic mismatch repair. Genes Dev 1996;10:1433-42.
53. Marsischky GT, Filosi N, Kane MF, Kolodner R. Redundancy of Saccharomyces cerevisiae MSH3 and MSH6 in MSH2-dependent mismatch repair. Genes Dcv 1996;10:407-20.
54. Greene CN, Jinks-Robertson S. Frameshift intermediates in homopolymer runs are removed efficiently by yeast mismatch repair proteins. Mol Cell Biol 1997;17:2844-50.
55. Sia EA, Kokoska RJ, Dominska M, Greenwell P, Petes TD. Microsatellite instability in yeast: dependence on repeat unit size and DMA mismatch repair genes. Mol Cell Biol 1997;17:2851-8.
56. Genschel J, Littman SJ, Drummond JT, Modrich P. Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha. JBiolChem 1998;273:19895-901.
57. Palombo F, laccarino I, Nakajima E, Ikejima M, Shimada T, Jiricny J. hMutSbeta, a heterodimer of hMSH2 and hMSH3, binds to insertion deletion loops in DNA. CurrBiol 1996;6:1181-4.
58. Habraken Y, Sung P, Prakash L, Prakash S. Binding of insertion/deletion DMA mismatches by the heterodimer of yeast mismatch repair proteins MSH2 and MSH3. CurrBiol 1996;6:1185-7.
59. Alani E. The Saccharomyces cerevisiae Msh2 and Msh6 proteins form a complex that specifically binds to duplex oligonucleotides containing mismatched DXA base pairs. Mol Cell Biol 1996;16:5604-15.
60. Drummond JT, Li GM, Longley MJ, Modrich P. Isolation of an hMSH2-p 160 heterodimer that restores DNA mismatch repair to tumor cells. Science 1995;26S:1909-12.
61. Prolla TA, Pang Q, Alan; E, Kolodner RD, Liskay RM. MLHI, PMS1, and MSH2 interactions during the initiation of DNA mismatch repair in yeast. Science l991;265:109l-3.
62. Li GM, Modrich P. Restoration of mismatch repair to nuclear extracts of H6 colorectal tumor cells by a heterodimer of human MutL homologs. Proc Nail Acad Sei USA 1995;92:1950-4.
63. Habraken Y, Sung P, Prakash L, Prakash S. Enhancement of MSH2-MSH3mediated mismatch recognition by the yeast MLH 1-PMS 1 complex. Curr Biol 1997;7:790-3.
64. Flores-Rozas H, Kolodner RD. The Saccharomyces cerevisiae MLH3 gene functions in AlSH3-dependent suppression of frameshift mutations. Proc Nad Acad Sei USA 1998;9S: 12404-9.
65. Drotschmann K, Aronshtam A, Fritz HJ, Marinus MG. The Escherichia coli MutL protein stimulates binding of Vsr and MutS to heteroduplex DNA. Nucleic Acids Res 1998;26:948-53.
66. Syngal S, Fox EA, Li C, et al. Interpretation of genetic test results for hereditary nonpolyposis colorectal cancer-Implications for clinical predisposition testing. JAMA 1999;2S2:247-53.
67. Sancar A. Excision repair invades the territory of mismatch repair. Nat Genet 1999;21:247-9.
68. Thibodeau SN, French AJ, Roche PC, et al. Altered expression of hMSH2 and hMLH I in tumors with microsatellite instability' and genetic alterations in mismatch repair genes. Cancer Res 1996;56:4836-!0.
69. Herman JG, Latif F, Veng Y, et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. Proc Nail Acad Sei USA 1994;91:9700-.
70. Herman JG, Merlo A, Mao L, et al. Inactivation of the CDKN2/pl6/MTSl gene is frequently associated with aberrant DNA methylation in all common human cancers. Cancer Res 1995;55:4525-30.
71. Merlo A, Herman JG, Mao L, et al. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor pl6/CDKN2/MTS1 in human cancers. NatMcd 1995;l:686-92.
72. Lengauer C, Kinzler KW, Vogelstein B. Genetic instability in colorectal cancers. Nature 1997;3S6:623-7.
73. Ahuja N, Mohan AL, Li Q, et al. Association benveen CpG island methylation and microsatellite instability in colorectal cancer. Cancer Res 1997;57: 3370-4.
74. Kane IMF, Loda M, Gaida GM, et al. Methylation of the hMLHl promoter correlates with lack of expression of hMLHl in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 1997;57: 808-11.
75. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLHl promoter hypermethylation in colorectal carcinoma. ProcKail Acad Sei USA 199S;95:6870-5.
76. Veigl ML, Kasturi L, Olechnowicz J, et al. Biallelic inactivation of hMLHl by epigenetic gene silencing, a novel mechanism causing human MSI cancers. Proc Nad Acad Sei USA 1998;95:8698-702.
77. Cunningham JM, Christensen ER, Tester DJ, et al. Hypermethylation of the hMLHl promoter in colon cancer with microsatellite instability. Cancer Res 199S;5S:3455-60.
78. Wheeler JMD, Beck NE, Kim HC, Tomlinson IPM, Mortensen NJM, Bodmer WF. Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: the predominant role of hMLHl. Proc Natl AcadSciUSA 1999;96:10296-301.
79. Simpkins SB, Bocker T, Svvisher EM, et al. MLH1 promoter methylation and gene silencing is the primary cause of microsatellite instability in sporadic endometrial cancers. Hum Mol Genet 1999;S:661-6.
80. Leung SY, Yuen ST, Chung LP, Chu KM, Chan AS, Ho JC. hMLHl promoter methylation and lack of hMLHl expression in sporadic gastric carcinomas with high-frequency microsatellite instability. Cancer Res 1999;59: 159-64.
81. Clark SJ, Harrison J, Molloy PL. Spl binding is inhibited by (m)Cp(m)CpG methylation. Gene 1997;195:67-71.
82. Prendergast GC, Ziff EB. Methylation-sensitive sequence-specific DN'A binding by the c-Myc basic region. Science 1991;251:186-9.
83. Jones PA, Laird PW. Cancer epigenetics comes of age. Nat Genet 1999;21:163-7.
84. Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DN'A (cytosine-5) methyltransferases (letter). Nat Genet 1998; 19:219-20.
85. Cameron EE, Bachman KE, Myohanen S, Herman JG, Baylin SB. Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer. Nat Genet 1999;21:103-7.
86. Bodmer WF. Inheritance of susceptibility to cancer in man. Cancer Surv 1982;1:1-18.
87. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-9.
88. Huang J, Papadopoulos N, McKinley AJ, et al. APC mutations in colorectal tumors with mismatch repair deficiency. Proc Nail Acad Sei USA 1996;93: 9049-54.
89. Homfray TF, Cottrell SE, Ilyas M, et al. Defects in mismatch repair occur after APC mutations in the pathogenesis of sporadic colorectal tumours. Hum Mutât 1998; 11:114-20.
90. Young J, Leggett B, Gustafson C, et al. Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum Mutât 1993;2:351-4.
91. Tomlinson IP, Novell! MR, Bodmer WF. The mutation rate and cancer. Proc Nat! Acad Sei USA 1996;93:14800-3.
92. Lane DP. p53 and human cancers. BrMedBull 1994;50:582-9.
93. Tomlinson IP, Bodmer WF. Failure of programmed cell death and differentiation as causes of tumors: some simple mathematical models. Proc Natl Acad Sci USA 1995;92:11130-1.
94. Zhang H, Richards B, Wilson T, et al. Apoptosis induced by overexpression ofhMSH2 or hMUïl. Cancer Res 1999;59:3021-7.
95. Eshleman JR, Casey G, Kochera ME, et al. Chromosome number and structure both are markedly stable in RER colorectal cancers and are not destabilized by mutation of p53. Oncogens 1998; 17:719-25.
96. Tomlinson I, Bodmer W. Selection, the mutation rate and cancer: ensuring that the tail does not wag the dog. NatMed 1999;5:11-12.
97. Bodmer WF. 1998 Runme Shaw Memorial Lecture: Somatic evolution of cancer. Ann AcadMcd Singapore 1999;28:323-9.
98. Branch P, Bicknell DC, Rowan A, Bodmer WF, Karran P. Immune surveillance in colorectal carcinoma (letter). Nat Genet 1995;9:231-2.
99. Cahill DP, Lengauer C, Yu J, et al. Mutations of mitotic checkpoint genes in human cancers. Nature 1998;392:300-3.
100. Markowitz S, VangJ, Myeroff L, et a!. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995;26S:1336-8.
101. Souza RF, Appel R, Yin J, et al. Microsatellite instability in the insulin-like growth factor II receptor gene in gastrointestinal tumours (letter). Nat Genet 1996;14:255-7.
102. Rampino N, Yamamoto H, lonov Y, et al. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997;21S:967-9.
103. Jass JR, Smyrk TC, Stewart SM, Lane MR, Lanspa SJ, Lynch HT. Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 1994;14: 1631-4.
104. Jass JR, Do KA, Simms LA, et al. Morphology of sporadic colorectal cancer with DN'A replication errors. Gut 1998;42:673-9.
105. Ruschoff J, Dietmaier W, Luttges J, et al. Poorly differentiated colonie adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am JPaihol 1997; 150:1815-25.
106. Jass Diagnosis of hereditary non-polyposis colorectal cancer. Histopathologund;y 1998;32:49I-7.
107. Jass JR, Edgar S. Unicryptal loss of heterozygosity in hereditary non-polyposis colorectal cancer. Pathology 1994;26:414-7.
108. Jass Colorectal adenomas in surgical specimens from subjects with hereditary non-polyposis colorectal cancer. Hiaopaihology 1995;27:263-7.
109. Konishi M, Kikuchi-Yanoshita R, Tanaka K, et al. Molecular nature of colon tumors in hereditary nonpolyposis colon cancer, familial polyposis, and sporadic colon cancer. Gastroenlerology 1996;11I:307-I7.